PanGen Biotech Inc (222110) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.122x

Based on the latest financial reports, PanGen Biotech Inc (222110) has a cash flow conversion efficiency ratio of -0.122x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-3.66 Billion ≈ $-2.48 Million USD) by net assets (₩30.03 Billion ≈ $20.35 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see PanGen Biotech Inc (222110) market capitalisation for the company's overall valuation and market capitalisation.

PanGen Biotech Inc - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how PanGen Biotech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

PanGen Biotech Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of PanGen Biotech Inc ranked by their cash flow conversion efficiency. Explore PanGen Biotech Inc (222110) cash flow quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Omesti Bhd KLSE:9008	0.045x
BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- F:BLH	0.003x
Indopoly Swakarsa Industry Tbk JK:IPOL	0.051x
Scan-D TWO:6195	0.083x
Grove Collaborative Holdings, Inc. NYSE:GROV	-0.093x
BlockchAIn Digital Infrastructure, Inc NYSE MKT:AIB	0.064x
Transcontinental Inc TO:TCL-B	0.002x
S P V I Public Company Limited BK:SPVI	0.102x

Annual Cash Flow Conversion Efficiency for PanGen Biotech Inc (2014–2024)

The table below shows the annual cash flow conversion efficiency of PanGen Biotech Inc from 2014 to 2024. View PanGen Biotech Inc stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩24.91 Billion ≈ $16.88 Million	₩2.99 Billion ≈ $2.02 Million	0.120x	+143.67%
2023-12-31	₩12.57 Billion ≈ $8.52 Million	₩-3.45 Billion ≈ $-2.34 Million	-0.275x	-35.00%
2022-12-31	₩17.22 Billion ≈ $11.67 Million	₩-3.50 Billion ≈ $-2.37 Million	-0.203x	-29.11%
2021-12-31	₩21.10 Billion ≈ $14.30 Million	₩-3.32 Billion ≈ $-2.25 Million	-0.158x	+52.17%
2020-12-31	₩14.21 Billion ≈ $9.63 Million	₩-4.68 Billion ≈ $-3.17 Million	-0.329x	-65.73%
2019-12-31	₩18.43 Billion ≈ $12.49 Million	₩-3.66 Billion ≈ $-2.48 Million	-0.199x	+4.56%
2018-12-31	₩26.94 Billion ≈ $18.26 Million	₩-5.61 Billion ≈ $-3.80 Million	-0.208x	-891.15%
2017-12-31	₩31.31 Billion ≈ $21.22 Million	₩-657.84 Million ≈ $-445.81K	-0.021x	+82.93%
2016-12-31	₩35.31 Billion ≈ $23.93 Million	₩-4.35 Billion ≈ $-2.94 Million	-0.123x	+49.74%
2015-12-31	₩6.56 Billion ≈ $4.45 Million	₩-1.61 Billion ≈ $-1.09 Million	-0.245x	-95.31%
2014-12-31	₩10.69 Billion ≈ $7.24 Million	₩-1.34 Billion ≈ $-908.12K	-0.125x	--

About PanGen Biotech Inc

KQ:222110 Korea Biotechnology

Market Cap

$43.71 Million

₩64.50 Billion KRW

Market Cap Rank

#22490 Global

#1449 in Korea

Share Price

₩4780.00

Change (1 day)

+0.21%

52-Week Range

₩4330.00 - ₩7340.00

All Time High

₩24450.00